Overexpression of connexin 43 using a retroviral vector improves electrical coupling of skeletal myoblasts with cardiac myocytes in vitro

被引:19
作者
Tolmachov O. [1 ]
Ma Y.-L. [2 ]
Themis M. [1 ]
Patel P. [2 ]
Spohr H. [2 ]
MacLeod K.T. [3 ]
Ullrich N.D. [3 ]
Kienast Y. [1 ]
Coutelle C. [1 ]
Peters N.S. [2 ]
机构
[1] Section of Molecular and Cellular Medicine, Division of Biomedical Sciences, Faculty of Life Sciences, London
[2] Department of Cardiac Electrophysiology, National Heart and Lung Institute, Imperial College London at St. Mary's Hospital, London
[3] Department of Cardiac Medicine, National Heart and Lung Institute, Imperial College London, London
关键词
Cardiac Myocytes; Electrical Coupling; Skeletal Myoblast; Primary Myoblast; Host Myocardium;
D O I
10.1186/1471-2261-6-25
中图分类号
学科分类号
摘要
Background: Organ transplantation is presently often the only available option to repair a damaged heart. As heart donors are scarce, engineering of cardiac grafts from autologous skeletal myoblasts is a promising novel therapeutic strategy. The functionality of skeletal muscle cells in the heart milieu is, however, limited because of their inability to integrate electrically and mechanically into the myocardium. Therefore, in pursuit of improved cardiac integration of skeletal muscle grafts we sought to modify primary skeletal myoblasts by overexpression of the main gap-junctional protein connexin 43 and to study electrical coupling of connexin 43 overexpressing myoblasts to cardiac myocytes in vitro. Methods: To create an efficient means for overexpression of connexin 43 in skeletal myoblasts we constructed a bicistronic retroviral vector MLV-CX43-EGFP expressing the human connexin 43 cDNA and the marker EGFP gene. This vector was employed to transduce primary rat skeletal myoblasts in optimised conditions involving a concomitant use of the retrovirus immobilising protein RetroNectin® and the polycation transduction enhancer Transfectam®. The EGFP-positive transduced cells were then enriched by flow cytometry. Results: More than four-fold over expression of connexin 43 in the transduced skeletal myoblasts, compared with non-transduced cells, was shown by Western blotting. Functionality of the overexpressed connexin 43 was demonstrated by microinjection of a fluorescent dye showing enhanced gap-junctional intercellular transfer in connexin 43 transduced myoblasts compared with transfer in non-transduced myoblasts. Rat cardiac myocytes were cultured in multielectrode array culture dishes together with connexin 43/EGFP transduced skeletal myoblasts, control non-transduced skeletal myoblasts or alone. Extracellular field action potential activation rates in the co-cultures of connexin 43 transduced skeletal myoblasts with cardiac myocytes were significantly higher than in the co-cultures of non-transduced skeletal myoblasts with cardiac myocytes and similar to the rates in pure cultures of cardiac myocytes. Conclusion: The observed elevated field action potential activation rat e in the co-cultures of cardiac myocytes with connexin 43 transduced skeletal myoblasts indicates enhanced cell-to-cell electrical coupling due to overexpression of connexin 43 in skeletal myoblasts. This study suggests that retroviral connexin 43 transduction can be employed to augment engineering of the electrocompetent cardiac grafts from patients' own skeletal myoblasts. © 2006 Tolmachov et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 33 条
[1]  
Anversa P., Nadal-Ginard B., Myocyte renewal and ventricular remodelling, Nature, 415, pp. 240-243, (2002)
[2]  
Zannad F., Briancon S., Juilliere Y., Mertes P.M., Villemot J.P., Alla F., Virion J.M., Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: The EPICAL Study. Epidemiologie de l'Insuffisance Cardiaque Avancee en Lorraine, J Am Coll Cardiol, 33, pp. 734-742, (1999)
[3]  
Keon W.J., Heart transplantation in perspective, J Card Surg, 14, pp. 147-151, (1999)
[4]  
Muller-Ehmsen J., Kedes L.H., Schwinger R.H., Kloner R.A., Cellular cardiomyoplasty - A novel approach to treat heart disease, Congest Heart Fail, 8, pp. 220-227, (2002)
[5]  
Scorsin M., Hagege A., Vilquin J.T., Fiszman M., Marotte F., Samuel J.L., Rappaport L., Schwartz K., Menasche P., Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. 2, J Thorac Cardiovasc Surg, 119, pp. 1169-1175, (2000)
[6]  
Ott H.C., Bonaros N., Marksteiner R., Wolf D., Margreiter E., Schachner T., Laufer G., Hering S., Combined transplantation of skeletal myoblasts and bone marrow stem cells for myocardial repair in rats, Eur J Cardiothorac Surg, 25, pp. 627-634, (2004)
[7]  
Hutcheson K.A., Atkins B.Z., Hueman M.T., Hopkins M.B., Glower D.D., Taylor D.A., Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts, Cell Transplant, 9, pp. 359-368, (2000)
[8]  
Jain M., DerSimonian H., Brenner D.A., Ngoy S., Teller P., Edge A.S., Zawadzka A., Wetzel K., Sawyer D.B., Colucci W.S., Apstein C.S., Liao R., Cell therapy attenuates deleterious ventricular remodelling and improves cardiac performance after myocardial infarction, Circulation, 103, pp. 1920-1927, (2001)
[9]  
Reinecke H., MacDonald G.H., Hauschka S.D., Murry C.E., Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair, J Cell Biol, 149, pp. 731-740, (2000)
[10]  
Assmus B., Schachinger V., Teupe C., Britten M., Lehmann R., Dobert N., Grunwald F., Alcher A., Urbich C., Martin H., Hoelzer D., Dimmeler S., Zeiher A.M., Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOP-CARE-AMI), Circulation, 106, pp. 3009-3017, (2002)